Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1182
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Drug Industry Antitrust Act
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1182
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1182
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Drug Industry Antitrust Act, 87-1&2
Author: United States. Congress. Senate. Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1928
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1928
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Drug Industry Antitrust Act
Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 942
Book Description
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 942
Book Description
Drug Industry Antitrust Act
Author: United States. Congress. House. Committee on the Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 938
Book Description
Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs.
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 938
Book Description
Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs.
Drug Industry Antitrust Act Hearings
Author:
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages :
Book Description
The amendments are also known as: Kefauver-Harris Drug Amendments.
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages :
Book Description
The amendments are also known as: Kefauver-Harris Drug Amendments.
Drug Industry Antitrust Act
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 457
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 457
Book Description
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.
Drug Industry Antitrust Act
Author: United States. Congress. House. Committee on the Judiciary
Publisher:
ISBN:
Category :
Languages : en
Pages : 934
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 934
Book Description
Drug Industry Antitrust Act
Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages :
Book Description
Drug Industry Antitrust Act
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 457
Book Description
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 457
Book Description
Drug Industry Antitrust Act
Author:
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 908
Book Description
Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs.
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 908
Book Description
Committee Serial No. 32. Considers legislation to eliminate anticompetitive practices in the patenting, licensing, and marketing of drugs, and to require FDA standardization of drug names and stricter safety and efficacy standards for new drugs.